Q4 FY25Published 30 May 2025Call held 30 May 2025
514183 Q4 FY25 Earnings Call Transcript & Analysis
EBITDA Margin—PAT Margin—
Standalone revenue grew by 20% in FY25, driven by strong domestic sales.
Read full transcript & analysis
Every earnings call for 514183 — management tone, guidance, KPIs and promise tracking, quarter by quarter.
514183 · 2 transcripts · Chemicals · latest Q4 FY25Black Rose Indus has 2 earnings calls on record here, a Chemicals company, most recently Q4 FY25. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Standalone revenue grew by 20% in FY25, driven by strong domestic sales.
Read full transcript & analysisEBITDA Margin 10.0%. Revenue from operations increased by about 48% year-on-year.
Read full transcript & analysis